Welcome to our dedicated page for MSP RECOVERY SEC filings (Ticker: MSPRZ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
MSPRZ filings document MSP Recovery, Inc.'s public-company reporting for a redeemable warrant security tied to its Class A common stock. The company's 8-K reports identify the MSPRZ warrants as OTC-traded redeemable warrants, each lot of 4,375 warrants exercisable for one share of Class A common stock at an exercise price of $0.4375 per share.
The filings also report material definitive agreements involving subsidiaries, including working-capital funding arrangements and disclosures tied to the company's existing credit facility. These records cover registered security classes, capital-structure terms, material events, and corporate reporting status for MSP Recovery, Inc.
MSP Recovery, Inc. entered into a letter agreement with Hazel Partners Holdings LLC, its working capital lender, under which Hazel made a one-time discretionary advance of $250,000 on January 26, 2026, to be used primarily for operating expenses. This advance increases the amount previously drawn under the facility’s Operational Collection Floor but is described as a standalone accommodation. The company states that this funding does not reinstate or reopen availability under the working capital credit facility and that, apart from this advance, no additional funding is currently available. MSP Recovery further notes it has no rights to, and no reasonable basis to expect, any further advances, and cautions that this payment should not be seen as a sign of future support or ongoing liquidity.
MSP Recovery, Inc. entered into a letter agreement with Hazel Partners Holdings LLC on January 19, 2026 for a one-time advance of $300,000 under its existing working capital credit facility. The funds were provided through the facility’s discretionary Operational Collection Floor and may be used solely for operating expenses.
The advance, funded on January 20, 2026, was subject to conditions under the credit agreement, including no default at the time of funding. MSP Recovery explains that this is a standalone accommodation that does not reinstate or expand availability under the working capital facility, which previously had reached approximately $6.0 million of aggregate advances. The company states that no additional funding is currently available under the facility and that it has no rights to, and no reasonable basis to expect, further advances from Hazel, cautioning that this payment should not be viewed as an indication of ongoing liquidity support.
MSP Recovery reports that it has entered into confidential settlement agreements in ongoing legal matters totaling $2.9 million in cash. Some of this cash will be shared with counterparties under the company’s existing participation and distribution agreements, so not all proceeds will stay with the company.
One preliminary mediated settlement with a property and casualty insurer includes a commitment to provide historical claims data, help reconcile current and future assigned Medicare claims, and make a cash payment to resolve historical claims. A separate confidential settlement was reached with a pharmaceutical defendant in litigation over alleged overpayments. Management notes that these settlements are still being finalized and warns that definitive agreements may not be executed or deliver the expected working capital or operational benefits.